FIGS, Inc. is a consumer-focused healthcare lifestyle and apparel company in the United States. The company is headquartered in Santa Monica, California.
| Revenue (TTM) | $666.10M |
| Gross Profit (TTM) | $443.68M |
| EBITDA | $53.29M |
| Operating Margin | 2.80% |
| Return on Equity | 10.00% |
| Return on Assets | 4.93% |
| Revenue/Share (TTM) | $4.05 |
| Book Value | $2.58 |
| Price-to-Book | 3.88 |
| Price-to-Sales (TTM) | 2.48 |
| EV/Revenue | 2.18 |
| EV/EBITDA | 27.26 |
| Quarterly Earnings Growth (YoY) | 748.00% |
| Quarterly Revenue Growth (YoY) | 28.00% |
| Shares Outstanding | $158.76M |
| Float | $151.82M |
| % Insiders | 4.67% |
| % Institutions | 96.41% |
Volatility is currently expanding
FIGS' stronger revenue outlook and customer growth support the bull case, but its big rally, richer valuation and cost pressure complicate the buy call.
FIGS shows how healthcare apparel is evolving through essential demand, broader wardrobes, Community Hubs and global growth, despite cost friction.
FIGS' outlook rests on scrubwear strength, rising active customers and a global push, even as tariffs, freight and marketing spending pressure margins.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on Tuesday, June 9, 2026, at 12:00 p.m. ET. The audio portion of the fireside chat will b.
Baron Focused Growth Fund had a disappointing start to 2026, with a decline of 4.99% (Institutional Shares) compared with a 3.52% loss for the Russell 2500 Growth Index (the Benchmark). Top contributors were Space Exploration Technologies Corp., FIGS, Inc., and Choice Hotels International, Inc. Top detractors were Tesla, Inc., CoStar Group, Inc., and On Holding AG.
FIGS delivered a standout Q1'26, with 28% revenue growth, 12% active customer growth, and raised full-year revenue and EBITDA guidance. Gross margin expanded despite tariff and freight headwinds, but management models further near-term margin pressure, especially in Q3, before recovery in Q4. International growth (+50% YoY) and demonstrated pricing power highlight multi-year runway, yet marketing spend at 18.4% of revenue raises sustainability concerns.
FIGS, Inc. (FIGS) Q1 2026 Earnings Call Transcript
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2026 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2026 Financial Highlights Net revenues were $159.9 million, an increase of 28.0% year over year, primarily du.
FIGS, GAP and CPRI enter the earnings season with strong momentum, margin discipline and positive ESPs, signaling potential earnings surprises.
The consensus price target hints at a 27.1% upside potential for Figs (FIGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
